![Pressemitteilung: Viatris veröffentlicht Nachhaltigkeitsbericht 2021 zu Entwicklung, ... | Presseportal Pressemitteilung: Viatris veröffentlicht Nachhaltigkeitsbericht 2021 zu Entwicklung, ... | Presseportal](https://cache.pressmailing.net/thumbnail/highlight/8646adb8-dcf4-4156-a2fd-5c655fd5d044/Teaser_Viatris%20Nachh~021_RGB_Viatris.jpg?crop=0,0,630,412)
Pressemitteilung: Viatris veröffentlicht Nachhaltigkeitsbericht 2021 zu Entwicklung, ... | Presseportal
![Viatris, Biocon snare historic interchangeability tag in diabetes for Lantus biosimilar | Fierce Pharma Viatris, Biocon snare historic interchangeability tag in diabetes for Lantus biosimilar | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1627565857/5204602349_c87b204860_b.jpg/5204602349_c87b204860_b.jpg?VersionId=ybOsC5OWYevotiYzafjxvtVxwSEDYzto)
Viatris, Biocon snare historic interchangeability tag in diabetes for Lantus biosimilar | Fierce Pharma
Biocon Biologics, Viatris gets European Commission nod for co-developed diabetes drug - The Hindu BusinessLine
![Biocon Biologics and Viatris Inc. Receive Historic Approval for First Interchangeable Biosimilar Semglee for the Treatment of Diabetes Biocon Biologics and Viatris Inc. Receive Historic Approval for First Interchangeable Biosimilar Semglee for the Treatment of Diabetes](https://medicircle.in/uploads/2021/july2021/biocon-biologics-viatris-approval-for-first-interchangeable-biosimilar-semglee.jpg)